These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16594764)

  • 1. The principle of parallelism in the design of studies to estimate treatment effects.
    Reichardt CS
    Psychol Methods; 2006 Mar; 11(1):1-18. PubMed ID: 16594764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding clinical trial outcomes: design, analysis, and interpretation.
    Jacobe HT; Leitenberger JJ; Bergstresser PR
    Dermatol Ther; 2007; 20(2):77-85. PubMed ID: 17537135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing specificity in psychotherapy: a meta-analysis of structural equivalence of placebo controls.
    Baskin TW; Tierney SC; Minami T; Wampold BE
    J Consult Clin Psychol; 2003 Dec; 71(6):973-9. PubMed ID: 14622072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving participant selection in disease management programmes: insights gained from propensity score stratification.
    Linden A; Adams JL
    J Eval Clin Pract; 2008 Oct; 14(5):914-8. PubMed ID: 19018926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of variance is easily misapplied in the analysis of randomized trials: a critique and discussion of alternative statistical approaches.
    Vickers AJ
    Psychosom Med; 2005; 67(4):652-5. PubMed ID: 16046383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The research design and methodological issues for the Cash and Counseling Evaluation.
    Brown RS; Dale SB
    Health Serv Res; 2007 Feb; 42(1 Pt 2):414-45. PubMed ID: 17244291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity scores: an introduction and experimental test.
    Luellen JK; Shadish WR; Clark MH
    Eval Rev; 2005 Dec; 29(6):530-58. PubMed ID: 16244051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical significance testing and clinical trials.
    Krause MS
    Psychotherapy (Chic); 2011 Sep; 48(3):217-22. PubMed ID: 21875234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical Bayesian design and analysis for drug and device clinical trials.
    Hobbs BP; Carlin BP
    J Biopharm Stat; 2008; 18(1):54-80. PubMed ID: 18161542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of chance baseline differences in repeated measurement designs.
    Overall JE; Doyle SR
    J Biopharm Stat; 1994 Jul; 4(2):199-216. PubMed ID: 7951275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating subject-treatment interaction when comparing two treatments.
    Gadbury GL; Iyer HK; Allison DB
    J Biopharm Stat; 2001 Nov; 11(4):313-33. PubMed ID: 12018782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General purpose of research designs.
    Jang R
    Am J Hosp Pharm; 1980 Mar; 37(3):398-403. PubMed ID: 7369224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail?
    Ospina-Tascón GA; Büchele GL; Vincent JL
    Crit Care Med; 2008 Apr; 36(4):1311-22. PubMed ID: 18379260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalizing results of randomized trials to clinical practice: reliability and cautions.
    Flather M; Delahunty N; Collinson J
    Clin Trials; 2006; 3(6):508-12. PubMed ID: 17170034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistics and the relationship of clinical research to clinical practice.
    Khuder SA; Kahaleh B
    J Rheumatol; 2009 Feb; 36(2):219-20. PubMed ID: 19208555
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials.
    Shrier I
    Stat Med; 2008 Jun; 27(14):2740-1; author reply 2741-2. PubMed ID: 18069729
    [No Abstract]   [Full Text] [Related]  

  • 19. A three-outcome design for randomized comparative phase II clinical trials.
    Hong S; Wang Y
    Stat Med; 2007 Aug; 26(19):3525-34. PubMed ID: 17262879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scientific inquiry. Study designs for program evaluation: how do we know what works?
    Cook PF
    J Spec Pediatr Nurs; 2009 Jan; 14(1):70-2. PubMed ID: 19161577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.